These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10200865)

  • 21. [Decreased platelet aggregation during angiotensin-converting enzyme inhibitor therapy. Results of a pilot study].
    Skowasch D; Lentini S; Andrié R; Jabs A; Bauriedel G
    Dtsch Med Wochenschr; 2001 Jun; 126(24):707-11. PubMed ID: 11446026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors.
    Fisman EZ; Grossman E; Motro M; Tenenbaum A
    J Hum Hypertens; 2002 Jun; 16(6):379-83. PubMed ID: 12037691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the role of angiotensin-converting enzyme inhibitors in congestive heart failure and after myocardial infarction?
    Nelson KM; Yeager BF
    Ann Pharmacother; 1996 Sep; 30(9):986-93. PubMed ID: 8876861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of aspirin in patients taking angiotensin converting enzyme inhibitors].
    Altin T; Kiliçkap M
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():14-9. PubMed ID: 18160362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using aspirin and ACE inhibitors in combination: why the hullabaloo?
    Peterson JG; Lauer MS
    Cleve Clin J Med; 2001 Jun; 68(6):569-74. PubMed ID: 11405620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?
    Hall D
    Cardiol Clin; 2001 Nov; 19(4):597-603. PubMed ID: 11715180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between aspirin and ACE Inhibitors: resolving discrepancies using a meta-analysis.
    Takkouche B; Etminan M; Caamaño F; Rochon PA
    Drug Saf; 2002; 25(5):373-8. PubMed ID: 12020174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activation in patients with congestive heart failure: do we have enough evidence to consider clopidogrel?
    Malinin AI; O'Connor CM; Dzhanashvili AI; Sane DC; Serebruany VL
    Am Heart J; 2003 Mar; 145(3):397-403. PubMed ID: 12660660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining aspirin with angiotensin converting enzyme inhibitors in heart failure: how safe is it?
    Mehta H; Mahajan A; Bansal N; Vaidya S; Pathak L
    J Assoc Physicians India; 1998 Nov; 46(11):953-6. PubMed ID: 11229224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
    Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure.
    Struckman DR; Rivey MP
    Ann Pharmacother; 2001 Feb; 35(2):242-8. PubMed ID: 11215846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors].
    Alimento M; Campodonico J; Santambrogio G; Rossi M; Trabattoni D; Celeste F; Guazzi M
    Cardiologia; 1997 Jun; 42(6):605-10. PubMed ID: 9289376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK; Giles T; Gonzales M; Horswell R; Kumar S; Lejuene A; Livaudais GF; Sarkar IC
    J La State Med Soc; 1997 Dec; 149(12):474-84. PubMed ID: 9425858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?
    Cleland JG; John J; Houghton T
    Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):625-31. PubMed ID: 11496056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acetylsalicylic acid (ASA)--is everything clear?].
    Spinar J; Vítovec J
    Vnitr Lek; 2002 Aug; 48(8):781-90. PubMed ID: 12425211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus angiotensin-converting enzyme inhibitor therapy alone on readmission rates in heart failure.
    Harjai KJ; Nunez E; Turgut T; Newman J
    Am J Cardiol; 2001 Feb; 87(4):483-7, A7. PubMed ID: 11179543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitors in the clinical setting of chronic congestive heart failure.
    Reyes AJ
    Am J Cardiol; 1995 Jun; 75(18):50F-55F. PubMed ID: 7778535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.